Revolutionizing Recovery: How Dr. Lundquist is Using BPC 157, TB 500, and Regenerative Therapies to Accelerate Healing Active Life Pain Center A new pilot study administered BPC 157 intravenously at doses 2040 higher than what's typically used in biohacking circles 10 mg on day one and 20 mg on day two. To put BPC 157 has already hit the mainstream, but should it hit your bloodstream? BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved